Insider trades

Mark J. Enyedy, Director of Biomarin Pharmaceutical BMRN, has filed 0 purchases and 5 sales on the open market. The latest trade was on 06/02.

Mark J. Enyedy

Director
First filing
23/02/07
Trades
39 trades
Buys / sales
0 / 5
12-month net buying
No record
Last trade
06/02

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan24/02/0524/02/0620,107 sh$29.28$588,732.96−3.3%
Open-market sale23/08/02–23/08/0423/08/043,007,554 sh4 trades$17.01avg.$51,144,787.97−84.5%